Recent News

• 08.22.2025 - Repligen Corporation to Present at Upcoming September Conferences
• 07.31.2025 - Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
• 07.29.2025 - Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
• 07.17.2025 - Repligen to Report Second Quarter 2025 Financial Results
• 05.27.2025 - Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
• 05.22.2025 - Repligen Corporation to Present at William Blair Growth Conference

Recent Filings

• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2025 - EX-99.1 EX-99.1
• 07.29.2025 - 8-K Current report
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities